Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study
- PMID: 38248372
- PMCID: PMC10814582
- DOI: 10.3390/diseases12010021
Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study
Abstract
This longitudinal study investigates the psychosocial effects of long-COVID Syndrome, a domain still not extensively researched. It specifically evaluates the quality of life, coping mechanisms, anxiety and depression levels in COVID-19 survivors, differentiating between those with and without long-COVID Syndrome. Conducted at the Victor Babes Hospital for Infectious Diseases and Pulmonology in Timisoara, Romania, the study utilized a cohort of patients diagnosed with mild to moderate COVID-19. The following standardized tools: WHOQOL-BREF for quality of life, COPE-60 for coping strategies, and the Hospital Anxiety and Depression Scale (HADS), were employed for the assessment. The sample consisted of 86 patients displaying persistent post-acute symptoms and 432 asymptomatic patients at the 6-month post-discharge mark. Patients with frequent post-acute symptoms reported significantly higher levels of fatigue (8.2 ± 1.4), cognitive difficulties (7.5 ± 1.6), and respiratory challenges (7.8 ± 1.3), along with a markedly lower overall quality of life (7.0 ± 1.5) compared to their asymptomatic counterparts. HADS scores revealed elevated depression (6.8 ± 1.9) and anxiety (7.1 ± 2.3) in the symptomatic group. Quality of life, as evaluated through the use of WHOQOL-BREF, showed lower scores in the symptomatic cohort across physical (58.8 ± 15.8), mental (56.3 ± 16.4), and social domains (50.2 ± 17.5). COPE-60 findings indicated a higher prevalence of disengagement (56.4%) and emotion-focused coping strategies (61.8%) in the symptomatic group, in contrast to 30.1% and 37.0%, respectively, in the asymptomatic group. The study highlights that long-COVID Syndrome significantly deteriorates the quality of life and is associated with increased depression and anxiety levels. The prevalent use of disengagement and emotion-focused coping strategies among patients with persistent symptoms suggests a need for enhanced psychosocial support tailored to this subgroup.
Keywords: COVID-19; long COVID; post-acute COVID.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome.Int J Gen Med. 2024 Mar 5;17:751-762. doi: 10.2147/IJGM.S453247. eCollection 2024. Int J Gen Med. 2024. PMID: 38476627 Free PMC article.
-
Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.JMIR Res Protoc. 2024 Jan 19;13:e51820. doi: 10.2196/51820. JMIR Res Protoc. 2024. PMID: 38241071 Free PMC article.
-
Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant. 2019 Nov;25(11):2234-2242. doi: 10.1016/j.bbmt.2019.06.024. Epub 2019 Jun 28. Biol Blood Marrow Transplant. 2019. PMID: 31260800 Clinical Trial.
-
Research of the Coronavirus Anxiety, Post-Traumatic Stress, Generalized Anxiety Disorder, Quality of Life, and Stress Coping Styles in COVID-19 Survivors.Psychol Rep. 2022 Dec;125(6):3069-3083. doi: 10.1177/00332941221129131. Epub 2022 Sep 22. Psychol Rep. 2022. PMID: 36134735 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
Cited by
-
Recognition of anxiety and depression using gait data recorded by the kinect sensor: a machine learning approach with data augmentation.Sci Rep. 2025 Jul 2;15(1):22489. doi: 10.1038/s41598-025-06535-3. Sci Rep. 2025. PMID: 40594318 Free PMC article.
-
Long-term sequelae of SARS-CoV-2 two years following infection: exploring the interplay of biological, psychological, and social factors.Psychol Med. 2024 Dec 2;54(15):1-11. doi: 10.1017/S0033291724002721. Online ahead of print. Psychol Med. 2024. PMID: 39618323 Free PMC article.
-
The faces of Long-COVID: interplay of symptom burden with socioeconomic, behavioral and healthcare factors.Qual Life Res. 2024 Oct;33(10):2855-2867. doi: 10.1007/s11136-024-03739-4. Epub 2024 Jul 30. Qual Life Res. 2024. PMID: 39078547
-
Deep learning analysis of long COVID and vaccine impact in low- and middle-income countries (LMICs): development of a risk calculator in a multicentric study.Front Public Health. 2025 Jun 26;13:1416273. doi: 10.3389/fpubh.2025.1416273. eCollection 2025. Front Public Health. 2025. PMID: 40642241 Free PMC article.
-
Neurologic manifestations of Long COVID in Colombia: a comparative analysis of post-hospitalization vs. non-hospitalized patients.Front Hum Neurosci. 2024 Aug 13;18:1450110. doi: 10.3389/fnhum.2024.1450110. eCollection 2024. Front Hum Neurosci. 2024. PMID: 39192882 Free PMC article.
References
-
- Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Features, Evaluation, and Treatment of Coronavirus (COVID-19) - PubMed
LinkOut - more resources
Full Text Sources